Research ArticleArticle
In Vitro and in Silico Identification and Characterization of Thiabendazole as a Mechanism-Based Inhibitor of CYP1A2 and Simulation of Possible Pharmacokinetic Drug-Drug Interactions
Roslyn S. Thelingwani, Simbarashe P. Zvada, Hugues Dolgos, Anna-Lena B. Ungell and Collen M. Masimirembwa
Drug Metabolism and Disposition June 2009, 37 (6) 1286-1294; DOI: https://doi.org/10.1124/dmd.108.024604